{"id":649952,"date":"2023-05-01T20:38:01","date_gmt":"2023-05-01T20:38:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=649952"},"modified":"2023-05-01T20:38:01","modified_gmt":"2023-05-01T20:38:01","slug":"alcoholic-hepatitis-market-analysis-market-size-epidemiology-leading-companies-and-competitive-analysis-companies-afimmune-durect-and-others","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/alcoholic-hepatitis-market-analysis-market-size-epidemiology-leading-companies-and-competitive-analysis-companies-afimmune-durect-and-others_649952.html","title":{"rendered":"Alcoholic Hepatitis Market Analysis, Market Size, Epidemiology, Leading Companies And Competitive Analysis | Companies &#8211; Afimmune, Durect, and others"},"content":{"rendered":"<div style=\"float:right; width:250px; padding:8px 10px 10px 10px;\">\n<div><a href=\"https:\/\/www.abnewswire.com\/uploads\/1682925233.jpeg\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"Alcoholic Hepatitis Market Analysis, Market Size, Epidemiology, Leading Companies And Competitive Analysis | Companies - Afimmune, Durect, and others\" src=\"https:\/\/www.abnewswire.com\/uploads\/1682925233.jpeg\" alt=\"Alcoholic Hepatitis Market Analysis, Market Size, Epidemiology, Leading Companies And Competitive Analysis | Companies - Afimmune, Durect, and others\" width=\"225\" height=\"225\" style=\"padding:0px 0px 10px 10px; border:0 solid !important;\" \/><\/a><\/div>\n<div class=\"quotes\">\n<div>Alcoholic Hepatitis Market<\/div>\n<\/div>\n<\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">DelveInsight\u2019s \u2018Alcoholic Hepatitis Market Insights, Epidemiology, and Market Forecast \u2013 2032\u2019 report deliver an in-depth understanding of the disease, historical and forecasted epidemiology as well as the market trends of Alcoholic Hepatitis in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.<\/div>\n<p style=\"text-align: justify;\">DelveInsight has launched a new report on &#8220;<strong>Alcoholic Hepatitis &#8211; Market Insights, Epidemiology, and Market Forecast-2032<\/strong>&rdquo;.<\/p>\n<p style=\"text-align: justify;\">DelveInsight&rsquo;s &ldquo;<strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/alcoholic-hepatitis-market?utm_source=abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=kpr\">Alcoholic Hepatitis &ndash; Market Insights, Epidemiology, and Market Forecast-2032<\/a><\/strong>&Prime; report delivers an in-depth understanding of the Alcoholic Hepatitis, historical and forecasted epidemiology as well as the&nbsp; Alcoholic Hepatitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/p>\n<p style=\"text-align: justify;\"><strong>Some of the key facts of the <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/alcoholic-hepatitis-market?utm_source=abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=kpr\">Alcoholic Hepatitis Market Report<\/a>:<\/strong><\/p>\n<ol style=\"text-align: justify;\" start=\"1\">\n<li>A literature review has also suggested that although Alcoholic Hepatitis is an acute condition, nearly 50% of patients with AH have established cirrhosis at the time of clinical presentation.<\/li>\n<li>Although patients drinking &ge; 30-50 g\/d for more than 5-10 years are considered at risk for developing Alcoholic Liver Disease (ALD), the disease does not develop in everyone with this amount of alcohol consumption. About 90% to 100% of heavy drinkers have steatosis, 10% to 35% have AH, and 8% to 20% have alcoholic cirrhosis.<\/li>\n<\/ol>\n<p style=\"text-align: justify;\"><strong>Key benefits of the report:<\/strong><\/p>\n<ol style=\"text-align: justify;\" start=\"1\">\n<li>Alcoholic Hepatitis market report covers a descriptive overview and comprehensive insight of the Alcoholic Hepatitis epidemiology and Alcoholic Hepatitis market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) &amp; Japan.)<\/li>\n<li>The Alcoholic Hepatitis market report provides insights on the current and emerging therapies.<\/li>\n<li>Alcoholic Hepatitis market report provides a global historical and forecasted market covering drug outreach in 7MM.<\/li>\n<li>The Alcoholic Hepatitis market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Alcoholic Hepatitis market.<\/li>\n<\/ol>\n<p style=\"text-align: justify;\"><strong>Got queries? Click here to know more about the <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/alcoholic-hepatitis-market?utm_source=abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=kpr\">Alcoholic Hepatitis Market Landscape<\/a>.<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Alcoholic Hepatitis Overview<\/strong><\/p>\n<p style=\"text-align: justify;\">Alcoholic hepatitis is inflammation of the liver caused by drinking alcohol. Alcoholic hepatitis is most likely to occur in people who drink heavily over many years. However, the relationship between drinking and alcoholic hepatitis is complex. Not all heavy drinkers develop alcoholic hepatitis, and the disease can occur in people who drink only moderately.<\/p>\n<p style=\"text-align: justify;\"><strong>The key players involved in the Alcoholic Hepatitis market:<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>Afimmune&nbsp;<\/li>\n<li>Durect<\/li>\n<li>And others<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong>The launch of the emerging therapies is expected to significantly impact the <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/alcoholic-hepatitis-market?utm_source=abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=kpr\">Alcoholic Hepatitis treatment scenario<\/a> in the upcoming years:-<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Drug covered<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>DS102<\/li>\n<li>DUR-928<\/li>\n<li>And others.<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong>Table of Contents:<\/strong><\/p>\n<p style=\"text-align: justify;\">1. Report Introduction<\/p>\n<p style=\"text-align: justify;\">2. Executive Summary<\/p>\n<p style=\"text-align: justify;\">3. SWOT analysis<\/p>\n<p style=\"text-align: justify;\">4. Alcoholic Hepatitis Patient Share (%) Overview at a Glance<\/p>\n<p style=\"text-align: justify;\">5. Alcoholic Hepatitis Market Overview at a Glance<\/p>\n<p style=\"text-align: justify;\">6. Alcoholic Hepatitis Disease Background and Overview<\/p>\n<p style=\"text-align: justify;\">7. Alcoholic Hepatitis Epidemiology and Patient Population<\/p>\n<p style=\"text-align: justify;\">8. Country-Specific Patient Population of Alcoholic Hepatitis<\/p>\n<p style=\"text-align: justify;\">9. Alcoholic Hepatitis Current Treatment and Medical Practices<\/p>\n<p style=\"text-align: justify;\">10. Unmet Needs<\/p>\n<p style=\"text-align: justify;\">11. Alcoholic Hepatitis Emerging Therapies<\/p>\n<p style=\"text-align: justify;\">12. Alcoholic Hepatitis Market Outlook<\/p>\n<p style=\"text-align: justify;\">13. Country-Wise Alcoholic Hepatitis Market Analysis (2019&ndash;2032)<\/p>\n<p style=\"text-align: justify;\">14. Market Access and Reimbursement of Therapies<\/p>\n<p style=\"text-align: justify;\">15. Market drivers<\/p>\n<p style=\"text-align: justify;\">16. Market barriers<\/p>\n<p style=\"text-align: justify;\">17. Appendix<\/p>\n<p style=\"text-align: justify;\">18. Alcoholic Hepatitis Report Methodology<\/p>\n<p style=\"text-align: justify;\">19. DelveInsight Capabilities<\/p>\n<p style=\"text-align: justify;\">20. Disclaimer<\/p>\n<p style=\"text-align: justify;\">21. About DelveInsight<\/p>\n<p style=\"text-align: justify;\"><strong>To request a sample report, click here <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/alcoholic-hepatitis-market?utm_source=abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=kpr\">Alcoholic Hepatitis Market Outlook 2032<\/a>.<\/strong><\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/delveinsight.com_56431.html\" rel=\"nofollow\">DelveInsight Business Research LLP<\/a><br \/><strong>Contact Person:<\/strong> Kritika Rehani<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=alcoholic-hepatitis-market-analysis-market-size-epidemiology-leading-companies-and-competitive-analysis-companies-afimmune-durect-and-others\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> 9193216187<br \/><strong>Address:<\/strong>304 S. Jones Blvd #2432  <br \/><strong>City:<\/strong> Las Vegas<br \/><strong>State:<\/strong> Nevada<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"https:\/\/www.delveinsight.com\/\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.delveinsight.com\/<\/a><\/p>\n<p><object type=\"text\/html\" data=\"https:\/\/www.delveinsight.com\/\" style=\"width:900px; height:400px;\"><\/object><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=alcoholic-hepatitis-market-analysis-market-size-epidemiology-leading-companies-and-competitive-analysis-companies-afimmune-durect-and-others\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Alcoholic Hepatitis Market DelveInsight\u2019s \u2018Alcoholic Hepatitis Market Insights, Epidemiology, and Market Forecast \u2013 2032\u2019 report deliver an in-depth understanding of the disease, historical and forecasted epidemiology as well as the market trends of Alcoholic Hepatitis in the United States, EU5 &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/alcoholic-hepatitis-market-analysis-market-size-epidemiology-leading-companies-and-competitive-analysis-companies-afimmune-durect-and-others_649952.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,435,405,406,404],"tags":[],"class_list":["post-649952","post","type-post","status-publish","format-standard","hentry","category-Business","category-Europe","category-Health-Medicine","category-Pharmaceuticals-Biotech","category-US"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/649952","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=649952"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/649952\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=649952"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=649952"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=649952"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}